These final results, along with a past report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 help the notion of targeting ACKR3 as a novel way to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Conditions. Based upon accessible science https://maryf283zpg9.wikigdia.com/user